# FDA Inspection 1101342 - Michigan Reproductive Medicine - July 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/michigan-reproductive-medicine/17dc9154-579a-40ca-b015-06204040d32c
Source feed: FDA_Inspections

> FDA Inspection 1101342 for Michigan Reproductive Medicine on July 16, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101342
- Company Name: Michigan Reproductive Medicine
- Inspection Date: 2019-07-16
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1270920 - 2025-05-13](https://www.keypedia.com/records/fda_inspections/michigan-reproductive-medicine/4b697113-516c-4922-acb3-296e623c4447)
- [FDA Inspection 1270920 - 2025-05-13](https://www.keypedia.com/records/fda_inspections/michigan-reproductive-medicine/a390e057-36cc-41bd-a9f1-b294857e71ef)
- [FDA Inspection 1023629 - 2017-07-11](https://www.keypedia.com/records/fda_inspections/michigan-reproductive-medicine/9e0661a6-2800-4364-8b1d-8bde188fe3d0)
- [FDA Inspection 959775 - 2015-12-16](https://www.keypedia.com/records/fda_inspections/michigan-reproductive-medicine/a66b6941-5b17-41ee-81f8-22760f032833)
- [FDA Inspection 829763 - 2013-04-01](https://www.keypedia.com/records/fda_inspections/michigan-reproductive-medicine/62ccccd2-7f37-43a7-910f-9bc220e8ee3c)

Company: https://www.keypedia.com/companies/michigan-reproductive-medicine/68e89bdc-0aa0-4657-95cd-c71b2997cc54

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d